Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 24;20(5):e3001622.
doi: 10.1371/journal.pbio.3001622. eCollection 2022 May.

Transcriptome-wide mapping reveals a diverse dihydrouridine landscape including mRNA

Affiliations

Transcriptome-wide mapping reveals a diverse dihydrouridine landscape including mRNA

Austin S Draycott et al. PLoS Biol. .

Abstract

Dihydrouridine is a modified nucleotide universally present in tRNAs, but the complete dihydrouridine landscape is unknown in any organism. We introduce dihydrouridine sequencing (D-seq) for transcriptome-wide mapping of D with single-nucleotide resolution and use it to uncover novel classes of dihydrouridine-containing RNA in yeast which include mRNA and small nucleolar RNA (snoRNA). The novel D sites are concentrated in conserved stem-loop regions consistent with a role for D in folding many functional RNA structures. We demonstrate dihydrouridine synthase (DUS)-dependent changes in splicing of a D-containing pre-mRNA in cells and show that D-modified mRNAs can be efficiently translated by eukaryotic ribosomes in vitro. This work establishes D as a new functional component of the mRNA epitranscriptome and paves the way for identifying the RNA targets of multiple DUS enzymes that are dysregulated in human disease.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Dihydrouridine-specific chemistry to map dihydrouridine sites in RNA with single-nucleotide resolution.
(A) Bulk nucleoside analysis of detects D in mRNA from WT but not DUS KO yeast. mRNA was purified by selecting for poly(A)+ and tRNAs were removed by size selection. (B) Structures of uridine, dihydrouridine, and tetrahydrouridine. (C) Primer extension analysis of synthetic 4D and 4U RNAs treated with NaBH4 and reverse transcribed with Super Script III RT. D-dependent RT stop positions are highlighted. (D) Schematic of D-seq library preparation. The data underlying this figure can be found in S3 Table. D, dihydrouridine; D-seq, dihydrouridine sequencing; DUS, dihydrouridine synthase; RT, reverse transcriptase; WT, wild-type.
Fig 2
Fig 2. D-seq identifies known and novel dihydrouridine sites in structured ncRNAs.
(A) Plots of cDNA end positions in Dus2 target tRNA ProAGG and Dus2, Dus4 target tRNA ArgCCG. D Peaks are highlighted. X scale in RPM and Y scale in bp. (B) Summary of known tRNA D positions and corresponding DUS. (C) Plots of cDNA end positions in snR5, snR13, and snR46 snoRNAs. D peaks are highlighted. TSS (transcription start site) of snR5. X scale in RPM and Y scale in bp. (D) snoRNA Ds occur primarily in stem-loop structures that resemble tRNA D loops. Plot of median DMS-induced mutation rate in 25 nt window flanking D site. Red trace is median DMS reactivity flanking D positions. Black dots are median DMS reactivity for randomly selected set of background positions. Blue trace is p-value for difference in DMS reactivity for sequences flanking D or background sites. (E) D sites occur in stem-loop structures of 16 H/ACA and 7 C/D box snoRNAs. The data underlying this figure can be found in S1 and S2 Tables. DMS, dimethyl sulfate; D-seq, dihydrouridine sequencing; ncRNA, non-coding RNA; snoRNA, small nucleolar RNA; TSS, transcription start site.
Fig 3
Fig 3. D-seq identifies dihydrouridine sites in mRNAs.
(A) Plots of cDNA end positions in ALD6 and SEC63 mRNAs. D peaks are highlighted. Scale in RPM and bp. (B) Distribution of D sites among mRNA features, and background distribution of features for all sites interrogated for D. (C) SDS-PAGE gels showing Top7 protein produced from U and D containing mRNAs with 4 different test codons. Denaturing glyoxal agarose gel showing mRNA integrity. All 4 test constructs showed no significant difference in protein produced per mRNA +/‒ D. Schematic of U/D mRNAs with U/D positions highlighted in red. (D) Plots of cDNA end positions for intronic D in RPL30 mRNA. D peak is highlighted. Scale in RPM and bp. (E) DUS KO strain has increased ratio of RPL30 intron mapping reads to exon mapping reads (p < 0.05, Student’s t test). Model of regulation of RPL30 pre-mRNA splicing by RPL30 protein. (F) mRNA sequences flanking Ds have higher DMS reactivity indicating greater flexibility. Plot of median DMS-induced mutation rate in 25 nt window flanking D site. Red trace is median DMS reactivity surrounding D positions. Black dots are median DMS reactivity for randomly selected set of background positions. Blue is p-value for difference in DMS reactivity for sequences flanking D or background sites. (G) D has multiple impacts on RNA structure. D both promotes loop formation and antagonizes duplex formation. The data underlying this figure can be found in S3 Table. D-seq, dihydrouridine sequencing; DMS, dimethyl sulfate; DUS, dihydrouridine synthase.

Comment in

Similar articles

Cited by

References

    1. Kato T, Daigo Y, Hayama S, Ishikawa N, Yamabuki T, Ito T, et al.. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005;65:5638–46. doi: 10.1158/0008-5472.CAN-05-0600 - DOI - PubMed
    1. Kuchino Y, Borek E. Tumour-specific phenylalanine tRNA contains two supernumerary methylated bases. Nature. 1978;271:126–9. doi: 10.1038/271126a0 - DOI - PubMed
    1. Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Gordon Robertson A, et al.. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9. doi: 10.1038/nature12222 - DOI - PMC - PubMed
    1. Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, et al.. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016;374:135–45. doi: 10.1056/NEJMoa1505917 - DOI - PMC - PubMed
    1. Xing F, Martzen MR, Phizicky EM. A conserved family of Saccharomyces cerevisiae synthases effects dihydrouridine modification of tRNA. RNA. 2002;8:370–81. doi: 10.1017/s1355838202029825 - DOI - PMC - PubMed

Publication types